Is ClearOne, Inc. (CLRO) a Buy, Sell, or Hold?
ClearOne, Inc.
NASDAQ:CLRO
$6.62 USD
$0.02 (0.3%)
- Volume
- 1.68M
- Average Volume
- 3.09M
- Market Capitalization
- $11.53M
- P/E Ratio
- -0.50
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $16.50
- Year Low
- $2.71
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.91
| Source | Headline |
|---|---|
|
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of ClearOne, Inc. (NYSE: CLRO)
NEW YORK, July 9, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating ClearOne, Inc. (NYSE: CLRO ) related to its merger with Cortigent, Inc. Upon completion of the proposed transaction, ClearOne shareholders will own approximately 12.7% to 14.4% of the outstanding equity in the combined company. prnewswire.com - 2026-07-09 13:23:00 |
|
CLRO Stock Alert: Halper Sadeh LLC is Investigating Whether ClearOne, Inc. is Obtaining a Fair Price for its Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merger of ClearOne, Inc. (NYSE: CLRO) and Cortigent, Inc. Upon closing of the Proposed Transaction, ClearOne shareholders will own 12.7% to 14.4% of the outstanding equity in the combined company.Halper Sadeh encourages ClearOne shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or [email protected] or z. businesswire.com - 2026-07-06 09:14:00 |
|
ClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani Medical
SALT LAKE CITY--(BUSINESS WIRE)--ClearOne, Inc. (Nasdaq: CLRO) (“ClearOne”) announced today that it has entered into a definitive agreement and plan of merger (the “Agreement”) among its wholly-owned subsidiary (“MergerSub”), Vivani Medical, Inc. (Nasdaq: VANI; “Vivani”), and Cortigent, Inc. (“Cortigent”), a wholly-owned subsidiary of Vivani, pursuant to which Cortigent will become a wholly-owned subsidiary of ClearOne (the “Transaction”) upon consummation. In connection with the Transaction, C. businesswire.com - 2026-07-02 08:00:00 |
|
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
Vivani proposes to merge Cortigent, Inc. with a wholly owned subsidiary of ClearOne, Inc. (Nasdaq: CLRO), and change the listed company's name and ticker to Cortigent Holdings, Inc. (d/b/a Cortigent) and "CRGT" Cortigent is a leading developer of brain computer interface ("BCI") devices based on precision neurostimulation technology ALAMEDA, Calif. globenewswire.com - 2026-07-02 08:00:00 |
